1. Home
  2. COHN vs BTMD Comparison

COHN vs BTMD Comparison

Compare COHN & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$11.10

Market Cap

38.7M

Sector

Finance

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.68

Market Cap

46.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
BTMD
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
46.2M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
COHN
BTMD
Price
$11.10
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
14.2K
365.7K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
722.22
EPS
1.36
N/A
Revenue
$275,564,000.00
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
$8.10
N/A
Revenue Growth
246.19
N/A
52 Week Low
$9.19
$1.27
52 Week High
$32.60
$3.58

Technical Indicators

Market Signals
Indicator
COHN
BTMD
Relative Strength Index (RSI) 42.93 49.37
Support Level $11.15 $1.63
Resistance Level $11.81 $2.17
Average True Range (ATR) 0.42 0.13
MACD 0.02 0.05
Stochastic Oscillator 19.11 80.00

Price Performance

Historical Comparison
COHN
BTMD

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: